To further discover the signature derived from the scRNA-seq of COVID-19 samples, we externally validated the PFB signature in another cohort, comprising 119 idiopathic pulmonary fibrosis (IPF) patients and 50 healthy controls [12]. This evidence concerns the gene KRT75 and COVID-19.